Legend Capital, established in 2001, is a Beijing-based venture capital firm and subsidiary of Legend Holdings Ltd. It manages multiple funds totaling up to US$700 million, focusing on early-stage IT companies and mid-market growth stage companies in China. Its investment sectors include network applications and services, outsourcing, professional services, IC design, key components, consumer goods, clean technology, healthcare, and modern services. Legend Capital actively supports its portfolio companies, providing business resources and tailored services to facilitate growth and enhance returns. Notable portfolio companies include Joyo.com (acquired by Amazon.com) and Spreadtrum Communications (Nasdaq: SPRD).
10/F, Tower A, Raycom Info.Tech Center, No.2 Ke Xue Yuan Nanlu, Zhong Guan Cun, Haidian District, Beijing 100190, China
Daqing Cai
Managing Director
Hao Chen
Managing Director and Head of Investment
Raymond CHEN
Co-Chief Investment Officer
Rui Chen
Managing Director
Frank Hong
Managing Director
Henry Ji
Executive Director
Yi Kang
Director
Richard Li
President
Jiaqing Li
Managing Director
Joon Sung Park
Executive Director
FAN Qihui
Executive Director
Jenking Shao
Managing Director and Partner
Zhenxing Shao
Partner / Managing Director
Jeff Wang
Managing Director
Junfeng Wang
Managing Director
Nengguang Wang
Managing Director and CFO
Piau-Voon Wang
COO
Tony WANG
VP
Ge Xinyu
Managing Director
Quan Zhou
Managing Director, Partner
Hank Zhou
Executive Director
Hongbin Zhou
Managing Director
Linan Zhu
Chairman
William Wen
Executive Director
Past deals in Asia
Core Medical Technology
Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
DeepWise
Venture Round in 2025
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
TBSTest
Series D in 2024
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
DK Medtech
Series E in 2024
DK Medtech, founded in 2015 and headquartered in Suzhou, China, specializes in the development and production of balloon catheter medical devices. The company is recognized as a leader in the medical device industry, focusing on innovative technologies that aim to meet the evolving challenges in healthcare. Through its commitment to excellence, DK Medtech strives to create impactful solutions that enhance patient care and improve medical outcomes.
Chaitin Tech
Venture Round in 2024
Beijing Chaitin Tech Co., Ltd. is a technology-oriented security company focused on addressing Internet security challenges. With a highly skilled research and development team, Chaitin Tech specializes in creating customized security products and services aimed at enhancing the security capabilities of enterprises. The company develops innovative web application security solutions that protect critical assets from evolving cyber threats. By leveraging advanced technologies and methods, Chaitin Tech strives to improve domestic security levels while aligning with global standards in cybersecurity.
Dearer Medical
Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
Leapstack
Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Alioth
Series A in 2023
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.
Ligatech Bioscience
Series D in 2023
Ligatech Bioscience, established in 2014 and headquartered in Qingpu, China, specializes in the design, development, production, and sales of medical devices for orthopedic and sports medicine. Its product portfolio includes molecular weight polyethylene suture and striped titanium plates, along with artificial ligaments and fixation systems. The company also offers technical advice and services to its users.
Alioth
Series A in 2022
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.
GalaxySpace
Series D in 2022
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
Shuhai Supply Chain
Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.
Nuclei System Technology
Venture Round in 2022
Nuclei System Technology is a pioneer in China for the commercialization of RISC-V processor licensing. The company focuses on the development of high-performance and low-power processors, along with their associated system-on-chip (SoC) platforms, aimed at meeting the increasing demand for embedded system applications globally. Nuclei's semiconductor technology is tailored for smart electronics, telecommunications, and computer processing cores. It specializes in creating configurable 32/64-bit RISC-V processors designed for artificial intelligence of things (AIoT) applications, thus delivering innovative solutions to its customers.
APTBIO
Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
TBSTest
Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Senscomm Semiconductor
Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company founded in 2018 and based in Suzhou, China. The company focuses on developing and providing innovative semiconductor solutions for various applications, including augmented reality (AR), virtual reality (VR), the Internet of Things (IoT), and electric vehicles (EV). Since its inception, Senscomm has successfully launched over 20 products to meet the growing global demand in these high-tech sectors.
Fit2Cloud
Series D in 2022
FIT2CLOUD, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers navigating multi-cloud environments, addressing challenges related to IT operation security and continuous application delivery. FIT2CLOUD offers a range of products, including its Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these offerings, FIT2CLOUD enables enterprises to effectively manage and control their cloud services, thereby facilitating digital transformation and improving operational efficiency.
MediLink Therapeutics
Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Hong Kong Asia Heart Centre
Series D in 2022
Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.
Hoteam Software
Series C in 2022
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Zshield
Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Leapstack
Series C in 2021
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Xbiome
Series B in 2021
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
ColorTech Bio
Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.
River Security
Series C in 2021
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.
Eswin
Series C in 2021
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.
Lunit
Venture Round in 2021
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Qixuan Technology
Series A in 2021
An AI & Robotics Company based in Shenzhen,China.
Wuxi Biortus Biosciences
Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.
H.Extract
Series C in 2021
H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Berry Oncology
Series B in 2021
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
QANDA(Mathpresso)
Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
XSKY Data Technology
Series E in 2021
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, enterprise, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise data center innovation.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
MicuRx Pharmaceuticals
Series E in 2020
MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.
Xbiome
Series B in 2020
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
LYNK Pharmaceuticals
Series A in 2020
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
Delova Biotech
Venture Round in 2020
Delova Biotech is focused on developing non-opioid analgesics aimed at pain treatment. The company leverages its extensive research and development experience, along with advanced preparation technology platforms, to enhance existing medications and create improved new analgesics in both China and the United States. Delova Biotech employs innovative technologies, including long-acting injection methods, transdermal formulations, nano-delivery systems, prodrug modifications, and techniques to improve the solubility of insoluble drugs. Through these efforts, the company strives to provide patients with higher quality medications that can significantly enhance their quality of life.
Exegenesis Bio
Seed Round in 2020
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Eswin
Series B in 2020
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.
Novast
Venture Round in 2020
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
TBSTest
Series A in 2020
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Feiyu
Series A in 2020
Shanghai Feiyu Network Technology Co., Ltd. operates a live e-commerce platform specializing in the trading of used luxury products, particularly handbags. The company conducts live broadcasts showcasing various luxury brand handbags through its mobile application, allowing users to view the products in real-time and make purchases at lower prices. In addition to handbags, Feiyu's platform includes a range of luxury items such as bags, accessories, watches, footwear, and clothing, catering to the growing market for pre-owned luxury goods in China.
Lunit
Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Xbiome
Series B in 2019
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
Gambol Pet Group
Series B in 2019
Gambol Pet Group Co., Ltd is a pet food manufacturer based in Liaocheng City, China, founded in 2006. The company specializes in a diverse range of products, including dry and wet pet food, real meat jerky treats, rawhide chews, and dental bones, catering to both dogs and cats. Its product lineup features various categories such as pet treats made from chicken, duck, pork, lamb, and fish, as well as wet food incorporating meat, fruits, and vegetables. Gambol Pet Group is committed to research and development, ensuring that its offerings include nutritional supplements and natural ingredients. The company distributes its products across Europe, Asia, and North America, serving a wide customer base. Under the leadership of Chairman and CEO Qin Hua, Gambol Pet Group continues to expand its presence in the pet food industry.
QANDA(Mathpresso)
Series B in 2019
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
Mancando
Series A in 2019
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, established in August 2015. The company specializes in providing a comprehensive range of car wearing parts essential for auto repair factories. Its product portfolio includes components for lubrication, braking, wiper, filtering, ignition, timing, and lighting systems. By integrating traditional auto parts management with internet and platform management, Mancando offers an innovative approach that allows customers to access all necessary automotive products from a single source.
GalaxySpace
Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.
AgotoZ
Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.
Shuhai Supply Chain
Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.
River Security
Series B in 2019
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.
Zongmu
Series C in 2019
Zongmu Technology Co. Ltd, established in 2013, is a Shanghai-based company specializing in automotive industry solutions and integration services. It operates research and development centers in Beijing and Shenzhen. Zongmu is renowned for its SurroundView ADAS (Advanced Driving Assistance System), which has been successfully implemented in major OEM automotive markets. The company has formed strategic partnerships with several OEM car manufacturers and tier-1 suppliers, solidifying its position as the leading SurroundView ADAS solution provider in the Chinese domestic market.
DeepWise
Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
New Horizon Health
Series C in 2019
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
Neusoft Huiju
Series A in 2019
Beijing Neusoft Huiju Information Technology Co., Ltd. is an independent business unit of Neusoft and Donghua focusing on enterprise information solutions. The company was established in 2007 and currently has a staff of more than 1,000 people. Headquartered in Beijing, the company has six marketing centers, eight delivery centers, and three R&D centers across the country, as well as overseas operations in Japan and the United States.
Black Sesame Technologies
Series B in 2019
Black Sesame Technologies is an AI digital imaging technology firm founded in 2016, with locations in Silicon Valley and Shanghai. The company specializes in developing solutions for real-world AI challenges, focusing on image processing, computing images, and embedded sensing platforms. It provides advanced algorithms for applications in smartphones, autonomous driving, and various consumer electronics. The firm conducts extensive research and development, including core algorithm development, ASIC design, and software systems for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to innovation, quality, and reliable service, leveraging the extensive industry experience of its team members. The company has designed automotive-grade system-on-chips (SoCs), including the high-computing Huashan Series and the cross-domain Wudang Series, aimed at enhancing intelligent vehicle solutions and driving the future of mobility.
Mancando
Series A in 2019
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, established in August 2015. The company specializes in providing a comprehensive range of car wearing parts essential for auto repair factories. Its product portfolio includes components for lubrication, braking, wiper, filtering, ignition, timing, and lighting systems. By integrating traditional auto parts management with internet and platform management, Mancando offers an innovative approach that allows customers to access all necessary automotive products from a single source.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.
Shanghai Cell Therapy Group
Series C in 2018
Shanghai Cell Therapy Group Co., Ltd., founded in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company offers a range of services, including technical consulting, technology transfer, and investment in the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on tumor immune cell therapy treatments. Additionally, the company provides cellular cold storage, develops cellular pharmaceuticals, and conducts antibody research, thereby enabling patients to undergo genetic testing and supplying valuable research data to cancer facilities.
Safe Medical Evaluation
Series C in 2018
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
AoHua
Series D in 2018
Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.
Udesk
Series C in 2018
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company offers an integrated platform that facilitates omnichannel communication, including call center operations, online customer service, and work order systems. Udesk enhances customer interactions across various channels such as text, mobile, phone, email, chat, and social media. Its solutions incorporate artificial intelligence, big data, and cloud computing technologies to improve customer relationship management and optimize marketing and customer success operations. Udesk serves a diverse range of industries, including healthcare, logistics, retail, education, and banking, among others. The company emphasizes connectivity and responsiveness to prioritize customer satisfaction.
Intelligence Indeed
Angel Round in 2018
Intelligence Indeed Co., Ltd. specializes in designing and developing intelligent software robots and chatbots aimed at automating enterprise processes. Founded in 2018 and based in Shenzhen, China, the company provides a range of solutions that enhance efficiency and reduce costs for businesses. Its offerings include finance solutions that incorporate risk control and self-service review systems, communication operation solutions for automating customer service tasks, and logistics solutions that facilitate cost estimation and information extraction. Additionally, Intelligence Indeed addresses complex decision-making challenges through its artificial intelligence and robotic process automation (RPA) technology, creating "smart assistant robots" utilized across various sectors, including finance and e-commerce.
Gaga Cafe
Series A in 2018
Gaga Café, founded in 2010 and headquartered in Shenzhen, China, operates a high-end café chain with a focus on providing a quality lifestyle experience. As of the first half of 2018, the company has expanded to 23 branches, including 21 independent locations and 2 partnerships with bookstores, strategically situated in key commercial areas of Shenzhen and Shanghai. The café chain is known for its menu featuring green and healthy options, including fresh fruit tea, brewed coffee, salads, pasta, handmade pizza, and a variety of snacks. Gaga Café has assembled a strong management team, attracting professionals from diverse backgrounds, including experienced food and beverage managers and IT specialists, all committed to enhancing the dining experience for its customers. The company is also exploring new restaurant concepts and collaborations with international food brands.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.
Qeebike
Series A in 2018
Qeebike Technology Co., Ltd, founded in October 2016 and headquartered in Hangzhou, China, specializes in electric bike rental and sharing services. The company offers a user-friendly mobile application that allows customers to hire, share, and unlock bikes conveniently using a QR code. It provides a high-capacity, high-performance ternary lithium battery, which lasts three times longer than typical electric vehicle batteries, thereby reducing operating costs and the frequency of replacements. Qeebike's service enables urban riders to navigate the city efficiently and safely, with adjustable pedaling and power modes, as well as a temporary parking feature for short breaks during rides. This innovative approach has led to a large volume of orders and significant profitability, presenting a viable transportation alternative for locals.
Editing and learning (CodePKU)
Series A in 2018
CodePKU Technology (Shenzhen) Co., Ltd. specializes in programming education for young learners, offering a variety of online courses that include subjects such as Scratch, Python, and preparation for the National Olympiad in Informatics. Established in 2012 in Shenzhen, China, the company provides both online and offline educational programs, training in children's products, and organizes programming competitions for youth. CodePKU also emphasizes international exchange programs and has developed an integrated educational technology system that combines technology research, curriculum development, and educational services. The initiative began as a project by a student team from the University of Tsukuba and has evolved into a successful venture focused on fostering creativity and technical skills among adolescents, contributing to their preparation for the global information age.
Spacety
Series B in 2018
Spacety, established in 2016 and headquartered in Changsha, China, is a microsatellite company specializing in developing and launching commercial micro and nano-satellites. It offers rapid, cost-effective, and comprehensive services to scientists, research institutions, and businesses for scientific experiments and technology demonstrations. As of now, Spacety has successfully launched four commercial microsatellites, with plans for more in the future.
Lunit
Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Aikucun
Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.
Zongmu
Series C in 2018
Zongmu Technology Co. Ltd, established in 2013, is a Shanghai-based company specializing in automotive industry solutions and integration services. It operates research and development centers in Beijing and Shenzhen. Zongmu is renowned for its SurroundView ADAS (Advanced Driving Assistance System), which has been successfully implemented in major OEM automotive markets. The company has formed strategic partnerships with several OEM car manufacturers and tier-1 suppliers, solidifying its position as the leading SurroundView ADAS solution provider in the Chinese domestic market.
Enjoy Dental Clinic
Series B in 2018
Enjoy Dental Clinic is a prominent dental care provider based in Beijing, China, established in 2007. It operates as a large-scale dental chain that integrates medical treatment, scientific research, education, and administrative functions. The clinic adheres to standardized practices in oral health treatment, employing advanced techniques such as 3D printing, digital-guided dental implants, and oral digital CT scanning. Additionally, Enjoy Dental Clinic prioritizes aseptic procedures and individualized care, utilizing a "one person, one machine" approach to ensure safety and hygiene. The clinic also offers franchising services, facilitating dental training and clinic development for aspiring dentists, thereby contributing to the growth of dental care expertise in the region.
JollyChic
Series C in 2018
JollyChic is a comprehensive e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, accessories, electronics, home goods, baby products, and more. The platform aims to provide customers with a variety of quality and stylish items, catering to various needs and preferences. By facilitating cross-border transactions, JollyChic enables shoppers to access suitable offers while ensuring decent quality in the products available for purchase.
Uoko.com
Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Innovent Biologics
Series E in 2018
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
Yosemite Clinic
Series A in 2018
Yosemite Clinic is a multidisciplinary medical center located in Central Pudong, Shanghai, offering a wide range of walk-in services in a modern and well-equipped environment. The clinic provides specialties including family medicine, internal medicine, gynecology, pediatrics, rehabilitation, sports medicine, dentistry, ophthalmology, dermatology, and medical cosmetology. It is particularly noted for its focus on Minimally Invasive Surgery and Ambulatory Surgery. The facility is equipped with advanced medical imaging technology, including CT, X-ray, and ultrasound, alongside a fully operational laboratory and pharmacy. The clinic's diverse team of healthcare professionals hails from both China and around the world, allowing them to offer services in multiple languages such as English, Japanese, Malay, Mandarin Chinese, and Cantonese, ensuring comprehensive care for a diverse patient population.
Youdao
Series A in 2018
Youdao, Inc. is an internet technology company based in Hangzhou, China, dedicated to providing online services focused on content, community, communication, and commerce. Founded in 2006, the company specializes in developing learning content, applications, and solutions tailored for a diverse range of users, including preschoolers, K-12 students, college students, and adult learners. Its offerings include the Youdao Dictionary, Youdao Cloudnote, and various online dictionary and translation tools. The company also markets smart devices such as the Youdao Smart Pen and Youdao Pocket Translator. Youdao's primary revenue source comes from its Learning services segment, which encompasses online courses like Youdao Premium Courses and NetEase Cloud Classroom. Additionally, the company provides online marketing services and technical support, operating as a subsidiary of NetEase, Inc.
DeepWise
Series B in 2018
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
INXX
Series B in 2018
INXX operates an online retail platform that serves as a hub for local and international fashion brands, with a particular emphasis on high-end professional sportswear. The platform is designed to cater to fashion leaders and artists, providing them access to a diverse range of fashionable clothing and accessories. By bringing together artists, designers, and creators from various fields, INXX promotes street-wear culture in China, enabling consumers to discover and purchase high-quality fashion products efficiently. The company aims to create a trendy environment that fosters collaboration and innovation within the fashion industry.
Qeebike
Series A in 2018
Qeebike Technology Co., Ltd, founded in October 2016 and headquartered in Hangzhou, China, specializes in electric bike rental and sharing services. The company offers a user-friendly mobile application that allows customers to hire, share, and unlock bikes conveniently using a QR code. It provides a high-capacity, high-performance ternary lithium battery, which lasts three times longer than typical electric vehicle batteries, thereby reducing operating costs and the frequency of replacements. Qeebike's service enables urban riders to navigate the city efficiently and safely, with adjustable pedaling and power modes, as well as a temporary parking feature for short breaks during rides. This innovative approach has led to a large volume of orders and significant profitability, presenting a viable transportation alternative for locals.
Muniu Technology
Series A in 2018
Muniu Technology is a Beijing-based company that specializes in developing advanced radar sensor systems. The firm focuses on millimeter-wave radar technology, which enhances the precision of electronic instruments through sophisticated radar measurement capabilities. Muniu Technology offers a range of products, including long-distance data processors, GPS units, landing motion sensors, and ultra long-distance data receptors. These products are designed for various applications, such as drones, automobiles, security systems, and smart home technologies. By providing innovative sensor and smart control solutions, Muniu Technology supports industrial clients in enhancing their technological capabilities.
Pony.ai
Series A in 2018
Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.
Hongliyu Cinema
Series B in 2018
Hongliyu Cinema is a rural cinema operator based in China, specializing in the management and operation of local theaters. The company provides services related to cinema investment, operation management, and professional training, aiming to enhance the efficiency of theater operations and improve digital media services. Additionally, Hongliyu Cinema is involved in film and television production as well as advertising operation services, contributing to the development of the local cinema landscape.
Berry Oncology
Series A in 2018
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
YUNJI
Angel Round in 2017
Yunji is a documentary film production company in China.
Yanwen Express
Series B in 2017
Beijing Yanwen Logistics Co., Ltd, established in 1998 and headquartered in Beijing, China, is a specialized logistics company providing freight forwarding and logistics services. The company focuses on serving e-commerce businesses by offering tailored international logistics solutions. Yanwen is equipped to handle a wide range of shipments, from small packages to larger goods, utilizing various modes of transportation including aircraft, trains, and automobiles. The firm emphasizes professional transport management to meet the diverse needs of its customers, supported by approvals from relevant government departments.
Ayshealth Technology
Series A in 2017
Ayshealth Technology, founded in 2014 and based in Beijing, China, specializes in developing a chronic disease management system. The company offers a guideline-based decision support (GDS) cloud service that aids physicians, patients, hospital managers, government entities, and insurance companies in monitoring and managing chronic disease data effectively. By leveraging artificial intelligence technologies, Ayshealth's platform enhances the diagnosis and treatment of chronic conditions, enabling healthcare professionals to make informed decisions and providing valuable data analytics to improve patient care.
Alo7
Series D in 2017
Alo7 is the leading provider of digital English Language Teaching (ELT) products and solutions in China, boasting over 10 million registered users and a network of more than 2,000 training school partners. The company operates an online tutoring platform designed to enhance English language learning for young Chinese students. By leveraging technology, Alo7 facilitates effective interactions among students, teachers, parents, and school administrators. The platform offers engaging and interactive classes that blend education with play, ensuring a high-quality learning experience. Alo7 is committed to transforming English education in China, redefining school management and fostering connections between educational institutions and homes in the mobile Internet era.
WeShine
Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.
Vingoo Juice
Series B in 2017
Vingoo Juice specializes in creating autonomous machines designed for producing fresh orange juice, primarily targeting the community market in China. By employing a "whole fruit extraction" method, these machines maximize juice yield from each orange, providing customers with enhanced value. The company integrates advanced technologies such as cloud computing, artificial intelligence, and mobile payment systems to elevate the consumer experience, making the process of obtaining fresh juice both intuitive and efficient.
Ucpaas
Series B in 2017
Ucpaas is a provider of cloud communication services based in Shenzhen, China, focused on developing an open platform for converged communication solutions. The company offers a comprehensive cloud computing platform that integrates the capabilities of major telecommunications operators and Internet networks. By utilizing open REST APIs and client SDKs for various operating systems, Ucpaas enables developers and businesses to easily implement voice, SMS, VoIP, and video communication solutions without the burden of hardware or network costs. With over a decade of experience in the VoIP communications industry, Ucpaas has amassed a large user base and holds a significant share of telecommunications resources. The company's specialized team, composed of members with extensive backgrounds in telecommunications and technology, drives innovation and product development, ensuring that Ucpaas remains a competitive player in the digital communication landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.